Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |